These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5312165)

  • 1. [Enhancement of neutralization of vaccinia virus by antiglobulin].
    Weeke-Lüttmann M
    Arch Gesamte Virusforsch; 1970; 31(1):28-32. PubMed ID: 5312165
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of the vaccinia virus plaque neutralization test.
    O'Brien TC; Myers MG; Tauraso NM
    Appl Microbiol; 1971 May; 21(5):968-70. PubMed ID: 4995735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of some simple methods of preparing gamma-globulin and antiglobulin sera for use in the indirect immunofluorescence technique.
    Mostratos A; Beswick TS
    J Pathol; 1969 May; 98(1):17-24. PubMed ID: 4187177
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):107-16. PubMed ID: 4126981
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of specificity of some commercial antiglobulin conjugates in indirect immunofluorescence tests.
    Mostratos A; Beswick TS
    J Pathol; 1969 May; 98(1):1-16. PubMed ID: 4981891
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the early antigens induced by vaccinia virus.
    Ueda Y; Tagaya I; Amano H; Ito M
    Virology; 1972 Sep; 49(3):794-800. PubMed ID: 4627344
    [No Abstract]   [Full Text] [Related]  

  • 7. Herpesvirus neutralization: induction of the persistent fraction by insufficient antibody.
    Wallis C; Melnick JL
    Virology; 1970 Sep; 42(1):128-37. PubMed ID: 4990056
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of the kinetics of neutralization of the vaccina virus by means of titration of the homologous antiserum.
    Rapicetta M; Mancini G; Santoro R
    Boll Ist Sieroter Milan; 1973; 52(4):315-20. PubMed ID: 4798236
    [No Abstract]   [Full Text] [Related]  

  • 9. Abortive replication of CV1 strain of vaccinia virus in human embryo kidney cells.
    Dunlap RC; Meyer HM
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):779-84. PubMed ID: 4587882
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of rheumatoid factor on the immune lysis of vaccinia virus-infected cells.
    Gipson TG; Daniels CA
    Clin Immunol Immunopathol; 1975 May; 4(1):16-23. PubMed ID: 1079172
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralizing activities of antisera to poxvirus soluble antigens.
    Appleyard G; Andrews C
    J Gen Virol; 1974 May; 23(2):197-200. PubMed ID: 4833605
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the non-neutralizable fraction of vaccinia virus.
    Majer M; Link F
    Clin Exp Immunol; 1970 Aug; 7(2):283-91. PubMed ID: 5312264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heat-labile factors on the neutralization of vaccinia virus by human.
    Takabayashi K; McIntosh K
    Infect Immun; 1973 Oct; 8(4):582-9. PubMed ID: 4200542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.
    Aksenov OA; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(4):488-98. PubMed ID: 6006816
    [No Abstract]   [Full Text] [Related]  

  • 15. Serological relationship of buffalopox virus to vaccinia and cowpox viruses.
    Kataria RS; Singh IP
    Acta Virol; 1970 Jul; 14(4):307-11. PubMed ID: 4394186
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralization of residual infectivity of Venezuelan equine encephalomyelitis virus by anti-gamma globulin.
    Hahon N
    J Gen Virol; 1970 Mar; 6(3):361-72. PubMed ID: 4984703
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of rheumatoid factor with infectious vaccinia virus-antibody complexes.
    Gipson TG; Daniels CA; Notkins AL
    J Immunol; 1974 Jun; 112(6):2087-93. PubMed ID: 4207730
    [No Abstract]   [Full Text] [Related]  

  • 18. Heat-labile accessory factor involved in vaccinia virus plaque neutralization.
    O'Brien TC; Hannah JE; Tauraso NM
    Arch Gesamte Virusforsch; 1973; 40(3):366-74. PubMed ID: 4735532
    [No Abstract]   [Full Text] [Related]  

  • 19. Some observations on the behavior of vaccinia virus particles with antiserum, particularly their agglutination.
    Galasso GJ; Sharp DG
    J Immunol; 1965 Oct; 95(4):737-42. PubMed ID: 5841056
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of staphylococcal protein A with virus-IgG complexes.
    Austin RM; Daniels CA
    J Immunol; 1974 Nov; 113(5):1568-74. PubMed ID: 4371490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.